Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EGCG Inhibits Tumor Growth in Melanoma by Targeting JAK-STAT Signaling and Its Downstream PD-L1/PD-L2-PD1 Axis in Tumors and Enhancing Cytotoxic T-Cell Responses
Dinoop Ravindran Menon, Yang Li, Takeshi Yamauchi, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1081-1081
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications
Mateusz Kciuk, Manzar Alam, Nemat Ali, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5246-5246
Open Access | Times Cited: 41
The current landscape of the antimicrobial peptide melittin and its therapeutic potential
Hai-Qian Zhang, Chengbiao Sun, Na Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 29
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
Wamidh H. Talib, Dima Awajan, Abdelrahim Alqudah, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1373-1373
Open Access | Times Cited: 29
The Promising Role of Polyphenols in Skin Disorders
Mohd Farhan
Molecules (2024) Vol. 29, Iss. 4, pp. 865-865
Open Access | Times Cited: 23
The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy
Dongming Li, Donghui Cao, Yuanlin Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
Current insight into the regulation of PD-L1 in cancer
Zhuandi Liu, Xibao Yu, Ling Xu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 62
Chemico-biological aspects of (−)- epigallocatechin- 3 -gallate (EGCG) to improve its stability, bioavailability and membrane permeability: Current status and future prospects
Revathy Sahadevan, Satyam Singh, Anupama Binoy, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 30, pp. 10382-10411
Closed Access | Times Cited: 48
Anticarcinogenic potentials of tea catechins
Xiaoxiang Li, Chang Liu, Shuling Dong, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 39
Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy
Carl A. Shirley, Gagan Chhabra, Deeba Amiri, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Green tea-mediated synthesis of silver nanoparticles: Enhanced anti-cancer activity and reduced cytotoxicity melanoma and normal murine cell lines
Monireh Golpour, Pedram Ebrahimnejad, Zahra Rezanejad Gatabi, et al.
Inorganic Chemistry Communications (2024) Vol. 161, pp. 111989-111989
Closed Access | Times Cited: 10
Focus on immune checkpoint PD-1/PD-L1 pathway: New advances of polyphenol phytochemicals in tumor immunotherapy
Kunjing Liu, Qi Sun, Qi Liu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113618-113618
Open Access | Times Cited: 32
Active ingredients of traditional Chinese medicine for enhancing the effect of tumor immunotherapy
Chao Yang, Dan Li, Chung‐Nga Ko, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Recent Strategies for Cancer Therapy: Polymer Nanoparticles Carrying Medicinally Important Phytochemicals and Their Cellular Targets
Metin Yıldırım, Melike Sessevmez, Samet Poyraz, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2566-2566
Open Access | Times Cited: 18
Phytochemicals as Immunomodulatory Agents in Melanoma
Claudio Tabolacci, Daniela De Vita, Antonio Facchiano, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2657-2657
Open Access | Times Cited: 13
Preclinical development and clinical studies of targeted JAK/STAT combined Anti-PD-1/PD-L1 therapy
Miaomiao Chen, Si-Liang Wang
International Immunopharmacology (2024) Vol. 130, pp. 111717-111717
Closed Access | Times Cited: 5
In vitro study of cold atmospheric plasma-activated liquids inhibits malignant melanoma by affecting macrophage polarization through the ROS/JAK2/STAT1 pathway
Cheng Chen, Shiyun Zhou, Xingyu Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116657-116657
Open Access | Times Cited: 5
Nature’s Arsenal: Harnessing the Capacity of Phytochemicals to Enhance Immune Checkpoint Inhibitor Therapy of Cancers: An Especial Attention to Brain Malignancies
Amir R. Afshari, Mehdi Sanati, Seyed Sajad Ahmadi, et al.
Cancer Letters (2024) Vol. 593, pp. 216955-216955
Closed Access | Times Cited: 5
Akkermansia muciniphila outer membrane protein regulates recruitment of CD8+ T cells in lung adenocarcinoma and through JAK–STAT signalling pathway
Yufen Xu, Xiaoli Tan, Qi Yang, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 5
Epigallocatechin-3-gallate at the nanoscale: a new strategy for cancer treatment
Wenxue Sun, Yizhuang Yang, Cuiyun Wang, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 676-690
Open Access | Times Cited: 5
miR395e from Manihot esculenta Decreases Expression of PD-L1 in Renal Cancer: A Preliminary Study
Joanna Bogusławska, Aizhan Rakhmetullina, Małgorzata Grzanka, et al.
Genes (2025) Vol. 16, Iss. 3, pp. 293-293
Open Access
T cell dysregulation in rheumatoid arthritis: Recent advances and natural product interventions
Mingyue Hu, Yujun Zhou, Zhongliu Yao, et al.
International Immunopharmacology (2025) Vol. 153, pp. 114499-114499
Closed Access
Nanoparticle-Based Delivery Systems for Phytochemicals in Cancer Therapy: Molecular Mechanisms, Clinical Evidence, and Emerging Trends
Mahmoud A.H. Mostafa, Hani M. J. Khojah
Drug Development and Industrial Pharmacy (2025), pp. 1-31
Closed Access
Polyphenols: Potential Applications in Cancer Therapy
María Oriol‐Caballo, Paz Moreno-Murciano, Rafael López‐Blanch, et al.
Molecular Nutrition & Food Research (2025)
Closed Access
Tea Polyphenol Coordinated with Nanoparticles of ZIF-8 and Coated with Polydopamine and PEG for Immuno-Oncotherapy
Nahar Jannatun, Yuqian Zhang, Ben Wu, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 6, pp. 4379-4389
Closed Access | Times Cited: 12
Melanoma Cellular Signaling Transduction Pathways Targeted by Polyphenols Action Mechanisms
Ecaterina Isacescu, Paul Chiroi, Oana Zănoagă, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 407-407
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top